Brief: Lupin- Divests U.S. Commercial Women's Health Specialty Business To Evofem
15/07/2024 12:02
July 15 (Reuters) - Lupin Ltd LUPN.NS :
* LUPIN- LUPIN DIVESTS U.S. COMMERCIAL WOMEN''S HEALTH
SPECIALTY
BUSINESS TO EVOFEM, INCLUDING SOLOSEC
* TOTAL CONSIDERATION OF UP TO USD 84 MILLION
Source text for Eikon: ID:nBSE2JRtP1
Further company coverage: LUPN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evofem Biosciences
See all newsBrief: Evofem Biosciences Adds Additional Manufacturing Capacity For Phexx To Support Global Growth Strategy
Brief: HUB Cyber Security Expands Into Women's Health With Zero-Cash Acquisition Of Evofem Notes
Evofem Biosciences Q1 sales edge up on higher pricing
Evofem Biosciences Q3 net sales rise
Brief: Evofem Anticipates Approval Of Merger With Aditxt At Upcoming Stockholder Meeting